Journal article
Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Abstract
BACKGROUND: Rosiglitazone has several properties that may affect progression of atherosclerosis. The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History (APPROACH) study was undertaken to determine the effect of the thiazolidinedione rosiglitazone on coronary atherosclerosis as assessed by intravascular ultrasound compared with the sulfonylurea glipizide.
METHODS AND …
Authors
Gerstein HC; Ratner RE; Cannon CP; Serruys PW; García-García HM; van Es G-A; Kolatkar NS; Kravitz BG; Miller DM; Huang C
Journal
Circulation, Vol. 121, No. 10, pp. 1176–1187
Publisher
Wolters Kluwer
Publication Date
March 16, 2010
DOI
10.1161/circulationaha.109.881003
ISSN
0009-7322